Skip to main content
. 2011 Feb 22;5:1–9. doi: 10.4137/CMRH.S6339

Table 1.

Demographic data and baseline hormonal characteristics.

r-FSH +hp-hMG (Group I) hp-hMG (Group II) Fixed-dose r-FSH (Group III) r-FSH dose-adjusted (Group IV)
Patient age (years) 31.27 ± 2.83 32.39 ± 2.70 33.72 ± 3.33 33.19 ± 3.17
Partner age (years) 33.72 ± 4.54 35.94 ± 4.27 36.23 ± 4.68 35.74 ± 5.09
Years of sterility 4.69 ± 1.45 5.04 ± 2.14 5.75 ± 2.94 5.49 ± 2.54
BMI (kg/m2) 21.87 ± 2.32 22.34 ± 2.62 22.61 ± 2.66 23.45 ± 2.83
First cycle 42 (84%) 43 (70.5%) 72 (61%) 54 (72%)
Baseline FSH (mIU/mL) 6.12 ± 1.30 5.92 ± 1.47 6.42 ± 1.53 6.17 ± 1.21
Baseline LH (mIU/mL) 4.56 ± 1.73 5.28 ± 2.74 5.20 ± 2.22 4.76 ± 1.85
Prolactin (ng/mL) 21.16 ± 9.73 21.76 ± 12.44 20.09 ± 11.42 17.98 ± 7.86
Baseline testosterone (ng/mL) 0.52 ± 0.23 0.49 ± 0.22 0.48 ± 0.14 0.62 ± 0.39
Baseline progesterone (pg/mL) 7.10 (4.40 ± 11.20) 5.85 (4.35 ± 8.40) 8.30 (5.70 ± 13.00) 9.60 (7.80 ± 17.00)

Note: Data are given as the mean (standard deviation) or frequency (%).

Abbreviations: r-FSH, recombinant FSH; hp-hMG, highly purified hMG.